Work that began at OMRF in the 1980s gives birth to a life-changing medication When Novartis announced in November that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have. The drug, known as Adakveo, is based […]
Rodger McEver
FDA approves new sickle cell drug with Oklahoma roots
Adakveo significantly reduces pain crises in sickle cell patients.
OMRF makes potential heart failure breakthrough
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.
OMRF selects 2019 Fleming Scholars
The scholars were selected from a pool of 70 applicants from across the state.
OMRF seeks 2019 Fleming Scholar applications
High school seniors, as well as college freshmen, sophomores and juniors, are eligible to apply.
New hope in the fight against sickle cell disease
For Mary Long, the answer to her pain may, literally, be right around the corner.